𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum level of interleukin-16 in multiple myeloma patients and its relationship to disease activity

✍ Scribed by Michael G. Alexandrakis; Freda H. Passam; Despina S. Kyriakou; Anna V. Christophoridou; Kostas Perisinakis; Aria Hatzivasili; Andreas Foudoulakis; Elias Castanas


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
86 KB
Volume
75
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Elevated serum concentration of hepatocy
✍ M.G. Alexandrakis; F.H. Passam; A. Sfiridaki; E. Kandidaki; P. Roussou; D.S. Kyr πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

## Abstract Hepatocyte growth factor (HGF) has been shown to be involved in angiogenesis, epithelial cell proliferation, and osteoclast activation. HGF and its receptor are expressed on myeloma cell lines and could be involved in the pathogenesis of bone destruction in multiple myeloma (MM). The ai

Elevation of serum levels of urokinase-t
✍ Miyake, Hideaki; Hara, Isao; Yamanaka, Kazuki; Gohji, Kazuo; Arakawa, Soichi; Ka πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 175 KB πŸ‘ 1 views

BACKGROUND. Several investigators have revealed that urokinase-type plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in serum as well as in tumor tissues in patients with various types of cancer. In this study, we examined whether the serum levels of uPA and uPAR could be used a